These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Toxicity data in addition to survival data are important in evaluating the applicability of a chemotherapy regimen of advanced non-small-cell lung cancer. Hotta K; Matsuo K; Ueoka H Lung Cancer; 2005 Aug; 49(2):277. PubMed ID: 15953658 [No Abstract] [Full Text] [Related]
6. Treatment of advanced non small-cell lung cancer in the elderly: from best supportive care to the combination of platin-based chemotherapy and targeted therapies. Gridelli C J Clin Oncol; 2008 Jan; 26(1):13-5. PubMed ID: 18165633 [No Abstract] [Full Text] [Related]
7. Platinum-based versus non-platinum-based chemotherapy in advanced non-small-cell lung cancer: does cisplatin versus carboplatin make a difference? Tiseo M; Boni L; Ardizzoni A J Clin Oncol; 2005 Sep; 23(25):6276-7; author reply 6277-8. PubMed ID: 16135504 [No Abstract] [Full Text] [Related]
9. Treatment options for patients with advanced-stage non-small-cell lung cancer: who are the "elderly" and who are the "unfit"? Gandara DR; Hesketh P Clin Lung Cancer; 2005 Nov; 7(3):154-5. PubMed ID: 16354308 [No Abstract] [Full Text] [Related]
10. To treat or not to treat advanced non-small-cell lung cancer patients with impaired performance status? Belvedere O; Grossi F J Clin Oncol; 2005 Oct; 23(28):7231-2; author reply 7232. PubMed ID: 16192611 [No Abstract] [Full Text] [Related]
11. [Combination chemotherapy for treatment of metastasing non-small-cell lung carcinoma. Monotherapy of combinations of two or three agents--a survey of a Cochrane review]. Mellemgaard A; Pappot H Ugeskr Laeger; 2009 Jun; 171(25):2084-7. PubMed ID: 19671386 [No Abstract] [Full Text] [Related]
12. Promising results achieved with a combination of chemotherapy and two retinoids in patients with advanced non-small-cell lung cancer. Nandan R Lung Cancer; 2006 Mar; 51(3):387-8. PubMed ID: 16406137 [No Abstract] [Full Text] [Related]
13. [Established new drugs in the chemotherapy of non-small-cell lung carcinoma (NSCLC)]. Serke M Dtsch Med Wochenschr; 2000 Feb; 125(8):225. PubMed ID: 10723459 [No Abstract] [Full Text] [Related]
14. Arterial carboxyhemoglobin concentrations as a prognostic predictor in elderly patients with advanced non-small-cell lung cancer. Yasuda H; Nakayama K; Ebihara S; Asada M; Sasaki T; Suzuki T; Inoue D; Yoshida M; Yamanda S; Yamaya M J Am Geriatr Soc; 2006 Apr; 54(4):712-3. PubMed ID: 16686889 [No Abstract] [Full Text] [Related]
15. UK body supports chemotherapy drugs for lung cancer. Mayor L BMJ; 2001 Jun; 322(7301):1508. PubMed ID: 11439982 [No Abstract] [Full Text] [Related]
16. [Combination chemotherapy with S-1 and cisplatin for non-small cell lung cancer]. Wataya H; Ichinose Y Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():194-6. PubMed ID: 16898001 [TBL] [Abstract][Full Text] [Related]
17. A phase II study of induction chemotherapy followed by concurrent chemoradiotherapy in elderly patients with locally advanced non-small-cell lung cancer. Giorgio CG; Pappalardo A; Russo A; Santini D; Di Rosa C; Di Salvo C; Castorina S; Marletta F; Bellissima G; Palermo N; Scuderi C; Bordonaro R Anticancer Drugs; 2007 Jul; 18(6):713-9. PubMed ID: 17762402 [TBL] [Abstract][Full Text] [Related]